Total planned funding: $467,027,451
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $128,254,489 |
South Africa | $49,060,207 |
Zambia | $42,212,085 |
Mozambique | $38,185,179 |
Asia Regional Program | $35,475,616 |
Vietnam | $21,318,908 |
West Africa Region | $13,460,980 |
Kenya | $12,900,128 |
Burundi | $11,898,532 |
Tanzania | $9,433,312 |
Zimbabwe | $9,054,888 |
Botswana | $8,696,354 |
Haiti | $8,675,317 |
Democratic Republic of the Congo | $8,281,460 |
Dominican Republic | $7,751,779 |
Ghana | $6,982,500 |
enumerations.Philippines | $6,341,584 |
Côte d'Ivoire | $6,088,453 |
Ethiopia | $5,596,768 |
India | $4,650,000 |
Malawi | $4,600,600 |
Rwanda | $4,308,060 |
Lesotho | $3,642,229 |
Papua New Guinea | $3,494,885 |
Uganda | $3,477,378 |
Eswatini | $3,080,500 |
South Sudan | $2,868,967 |
Indonesia | $2,330,000 |
Angola | $2,250,000 |
Namibia | $1,947,275 |
Western Hemisphere Region | $709,018 |
Cambodia | $0 |
Caribbean Region | $0 |
Organizational Types
NGO | $467,027,451 |
Program Areas
Care | $142,927,176 |
Treatment | $121,101,220 |
Prevention | $106,686,383 |
Testing | $48,158,310 |
Governance and Systems | $48,154,362 |
Budget Codes
HTXS: Treatment: Adult Treatment | $106,273,636 |
HKID: Care: Orphans and Vulnerable Children | $63,878,070 |
HBHC: Care: Adult Care and Support | $58,809,201 |
HVOP: Sexual Prevention: Other Sexual Prevention | $49,795,058 |
HVCT: Testing: HIV Testing and Counseling | $48,158,310 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $26,426,807 |
HLAB: Laboratory Infrastructure | $17,534,494 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $16,966,253 |
OHSS: Health Systems Strengthening | $15,512,808 |
HVSI: Strategic Information | $15,107,060 |
HVTB: Care: TB/HIV | $11,482,986 |
PDTX: Treatment: Pediatric Treatment | $9,745,470 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,399,819 |
PDCS: Care: Pediatric Care and Support | $8,756,919 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,569,754 |
HMIN: Biomedical Prevention: Injection Safety | $413,860 |
HMBL: Biomedical Prevention: Blood Safety | $114,832 |
Top Partner Programs
FHI 360:
$467,027,451
View countries